Skip to main content
David Jacobsohn, MD, Pediatric Hematology & Oncology, Washington, DC

DavidAJacobsohnMDScM

Pediatric Hematology & Oncology Washington, DC

Professor, Pediatrics, George Washington University School of Medicine and Health Sciences

Dr. Jacobsohn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jacobsohn's full profile

Already have an account?

  • Office

    111 Michigan Ave
    Washington, DC 20010
    Phone+1 888-884-2327

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1996 - 1999
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1996

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2010 - 2026
  • MD State Medical License
    MD State Medical License 2000 - 2026
  • VA State Medical License
    VA State Medical License 2020 - 2026
  • IL State Medical License
    IL State Medical License 2002 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Top Doctors:Washington DC Area Castle Connolly, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma  
    Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

  • Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
    David Jacobsohn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • First Patient Begins Newly Approved Sickle Cell Gene Therapy
    First Patient Begins Newly Approved Sickle Cell Gene TherapyOctober 21st, 2024
  • Liaison's Fully AGNIS-Compatible BMT Registry to Debut at BMT Tandem Meetings
    Liaison's Fully AGNIS-Compatible BMT Registry to Debut at BMT Tandem MeetingsJanuary 26th, 2016
  • Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)
    Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)July 30th, 2014
  • Join now to see all